National Healthcare Properties Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
NHPBP$25.44+0.0%Stored close · as of Oct 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Real estate investments, at cost: | ||
| Land | $190,082 | $207,987 |
| Buildings, fixtures and improvements | 2,012,401 | 2,120,352 |
| Acquired intangible assets | 284,447 | 293,295 |
| Total real estate investments, at cost | 2,486,930 | 2,621,634 |
| Less: accumulated depreciation and amortization | (725,831) | (681,977) |
| Total real estate investments, net | 1,761,099 | 1,939,657 |
| Cash and cash equivalents | 21,652 | 46,409 |
| Restricted cash | 52,443 | 44,907 |
| Derivative assets, at fair value | 19,206 | 28,370 |
| Straight-line rent receivable, net | 22,841 | 26,325 |
| Operating lease right-of-use assets | 7,480 | 7,713 |
| Prepaid expenses and other assets | 40,033 | 35,781 |
| Deferred costs, net | 21,269 | 15,997 |
| Total assets | $1,946,023 | $2,145,159 |
| LIABILITIES AND EQUITY | ||
| Mortgage notes payable, net | $779,160 | $808,995 |
| Credit facilities | 362,216 | 361,026 |
| Market lease intangible liabilities, net | 6,125 | 8,165 |
| Accounts payable and accrued expenses (including $30,267 and $295 due to related parties as of December 31, 2024 and 2023, respectively) | 89,575 | 48,356 |
| Operating lease liabilities | 8,109 | 8,038 |
| Deferred rent | 7,217 | 6,500 |
| Distributions payable | 3,496 | 3,496 |
| Total liabilities | 1,255,898 | 1,244,576 |
| Stockholders’ Equity | ||
| 7.375% Series A cumulative redeemable perpetual preferred stock, $0.01 par value, 4,740,000 authorized as of December 31, 2024 and 2023; 3,977,144 issued and outstanding as of December 31, 2024 and 2023 | 40 | 40 |
| 7.125% Series B cumulative redeemable perpetual preferred stock, $0.01 par value, 3,680,000 authorized; 3,630,000 issued and outstanding as of December 31, 2024 and 2023 | 36 | 36 |
| Common stock, $0.01 par value, 300,000,000 shares authorized, 28,296,439 shares and 27,886,255 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 1,132 | 1,115 |
| Additional paid-in capital | 2,533,706 | 2,509,303 |
| Accumulated other comprehensive income (loss) | 16,640 | 23,464 |
| Distributions in excess of accumulated earnings | (1,866,994) | (1,639,804) |
| Total stockholders’ equity | 684,560 | 894,154 |
| Non-controlling interests | 5,565 | 6,429 |
| Total equity | 690,125 | 900,583 |
| Total liabilities and equity | $1,946,023 | $2,145,159 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.